Drug Development Solutions

31. Comprehensive Services For Ophthalmic Drug Development 4/9/2024

    With our specialized support, you can be confident that your ophthalmic drug will not only meet regulatory standards but also address unmet medical needs in the most expedited manner possible.

32. Early Development: Accelerating Molecules Through To Proof-Of-Concept 3/3/2022

    Our integrated approach brings together drug substance, drug product and clinical activities, supporting the expediting of lead molecules from FIH into POC trials.

33. Drug Development And CMC Testing Solutions 4/12/2024

    Learn how a partner with comprehensive services can help you reduce development risks, shorten time to market, and navigate complex global regulations with ease.

34. Improving CLD Efficiency With An Innovative Platform

    Cell line development (CLD) bottlenecks can stall progress on the path to clinical trials. Examine how a novel CLD platform can accelerate development for efficient protein and vaccine production.

35. Drug Discovery Bioanalytical Solutions: Quick Turnarounds For Lead Optimization 2/5/2025

    Leverage rapid, high-quality discovery bioanalysis to streamline your drug development process, optimize lead compounds, and meet evolving timelines with confidence.

36. Bridging Molecules From Early Discovery To POC And Beyond 1/2/2024

    Learn how this partnership improves flexibility for customers, offers dedicated project teams, and enables a bespoke service that is tailored to each development program.

37. GENE TO GMP*: First-In-Human In 8 Months With Optimized Cost 3/27/2025

    We drive innovation and excellence in biologics, offering integrated solutions that help clients efficiently advance their research and successfully bring their products to market.

38. Testing Solutions For Antibody-Based Products 4/22/2024

    Explore our suite of analytical testing services for antibody-based drugs, encompassing feasibility studies, method development, validation, routine testing, and stability assessments, all aligned with rigorous regulatory standards.

39. Antibody Drug Conjugates: Link Your Antibody To Its Fullest Potential

    Learn how our parallel development service works seamlessly with our existing antibody capabilities, helping to accelerate your ADC program and reach market faster.

40. A CDMO With Oral Solid Dose And Sterile Injectable Expertise 6/6/2022

    Societal specializes in modified-release formulations, including those for high potent and DEA controlled substances.